Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.5K Sell
4,105
-56,800
-93% -$254K ﹤0.01% 6778
2025
Q4
$292K Buy
60,905
+51,305
+534% +$252K ﹤0.01% 5763
2025
Q3
$42.9K Buy
9,600
+6,100
+174% +$20.4K ﹤0.01% 6458
2025
Q2
$9.13K Buy
3,500
+2,100
+150% +$7.1K ﹤0.01% 6879
2025
Q1
$5.47K Sell
1,400
-13,400
-91% -$56.6K ﹤0.01% 6967
2024
Q4
$59.1K Buy
+14,800
New +$84.8K ﹤0.01% 6238
2024
Q3
Sell
-3,000
Closed -$12K 7983
2024
Q2
$12K Sell
3,000
-3,079
-51% -$15.9K ﹤0.01% 6617
2024
Q1
$26.1K Sell
6,079
-25,291
-81% -$94K ﹤0.01% 6415
2023
Q4
$126K Buy
31,370
+16,370
+109% +$69.8K ﹤0.01% 6088
2023
Q3
$88.8K Buy
15,000
+13,424
+852% +$98.4K ﹤0.01% 5948
2023
Q2
$14.3K Buy
1,576
+1,120
+246% +$10K ﹤0.01% 6673
2023
Q1
$3.62K Buy
+456
New +$4.92K ﹤0.01% 7129
2022
Q4
Sell
-109
Closed -$2K 7924
2022
Q3
$2K Buy
+109
New +$1.84K ﹤0.01% 7470

Other funds holding IONR

Morgan Stanley's IONR Position: Q1 2026 in Review

Morgan Stanley reduced its Ioneer (IONR) stake by 93% in Q1 2026, selling an estimated $254K and leaving 4,105 shares worth $17.5K. The position accounts for ﹤0.01% of the portfolio, ranked #6778.

Morgan Stanley first reported a position in IONR in Q3 2022 and has held it in 13 quarters since. The position peaked at $292K in Q4 2025. 22 funds tracked by Wall St. Rank hold IONR as of Q1 2026.

  • Morgan Stanley held 4,105 shares of Ioneer worth $17.5K as of Q1 2026.
  • Morgan Stanley sold 56,800 Ioneer shares in Q1 2026, an estimated $254K.
  • Ioneer made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #6778 holding.
  • Morgan Stanley first reported a position in Ioneer in Q3 2022 and has held it in 13 quarters since.
  • Morgan Stanley's Ioneer position peaked at $292K in Q4 2025.
  • 22 funds tracked by Wall St. Rank held Ioneer as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.